Andrew Hull

Andrew Hull

Net worth: 3 002 $ as of 31/05/2026

63 year
Health Technology
Consumer Services
Commercial Services

Profile

Mr. Andrew Hull is a Chairman at InMed Pharmaceuticals, Inc. Mr. Hull was previously employed as a Chairman by Illinois Biotechnology Industry Organization, a Vice President-Global Alliances by Takeda Pharmaceuticals U.S.A., Inc., a Vice President-Specialty Therapeutics by Immunex Corp., and a Trustee by Kenyon College.
He also served on the board at Zucara Therapeutics, Inc. He received his undergraduate degree from Kenyon College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
19/12/2025 1,912 ( 0.06% ) 3 002 $ 31/05/2026

Andrew Hull active positions

CompaniesPositionStart
INMED PHARMACEUTICALS INC. Chairman -

Former positions of Andrew Hull

CompaniesPositionEnd
Director/Board Member 01/03/2020
Corporate Officer/Principal 01/04/2018
Corporate Officer/Principal 01/07/2002
Director/Board Member -
Chairman -
See the detail of Andrew Hull's experience

Training of Andrew Hull

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

70

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!